| 1 |
1933 Industries Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 2 |
1CM Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 3 |
3D Medicines Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 4 |
3SBio Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 5 |
4Front Ventures Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 6 |
60 Degrees Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 7 |
Aarey Drugs and Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 8 |
Aarti Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 9 |
Aarti Pharmalabs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 10 |
Aayush Wellness Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 11 |
Abbisko Cayman Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 12 |
Abbott India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 13 |
Abbott Laboratories (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 14 |
Abbott Laboratories Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 15 |
AbbVie Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 16 |
AbClon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 17 |
Abeona Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 18 |
Abingdon Health PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 19 |
AbL Diagnostics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 20 |
Abnova Taiwan Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 21 |
ABPRO Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 22 |
ACADIA Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 23 |
Accent Microcell Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 24 |
Access Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 25 |
AccuStem Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 26 |
ACELYRIN Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 27 |
Aceragen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 28 |
Ache Laboratorios Farmaceuticos S.A. (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 29 |
Achieve Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 30 |
ACME Laboratories Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 31 |
Acorda Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 32 |
Acrobiosystems Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 33 |
Acrux Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 34 |
Actavia Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 35 |
AcuCort AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 36 |
Acura Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 37 |
Adagene Inc (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 38 |
Adaptogenics Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 39 |
Adastra Holdings Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 40 |
ADBiotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 41 |
Addex Therapeutics Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 42 |
Adimmune Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 43 |
Adlai Nortye Ltd (ADR) (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 44 |
Adline Chem Lab Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 45 |
ADMA Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 46 |
Advanced Enzyme Technologies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 47 |
Advent Pharma Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 48 |
Advicenne SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 49 |
Aelis Farma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 50 |
Aequus Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 51 |
AFT Pharmaceuticals Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 52 |
Agentix Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 53 |
Agenus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 54 |
Agimexpharm Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 55 |
AGP Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 56 |
AHN-GOOK PHARMACEUTICAL Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 57 |
AIM ImmunoTech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 58 |
AIM Vaccine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 59 |
Ainos Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 60 |
Aion Therapeutic Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 61 |
AiXin Life International Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 62 |
Ajanta Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 63 |
Akanda Corp (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 64 |
Akebia Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 65 |
Akums Drugs and Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 66 |
AL Kindi of Veternry Vns Co Mxd Jnt Stck (Iraq) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 67 |
Al Mansour Pharmaceuticals Industries Co (Iraq) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 68 |
Alar Pharmaceuticals Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 69 |
Albert David Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 70 |
Alembic Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 71 |
Alimera Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 72 |
Alimtiaz Investment Group Co KSCP (Kuwait) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 73 |
Alivus Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 74 |
ALK-Abello A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 75 |
Alkaloid AD Skopje (Republic of North Macedonia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 76 |
Alkem Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 77 |
Alkermes Plc (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 78 |
Allergy Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 79 |
Alliance Pharma plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 80 |
ALLIED BIOTECH CORP (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 81 |
Allied Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 82 |
Almirall SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 83 |
Almujtama Alraida Medical Co SJSC (Saudi Arabia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 84 |
Alnylam Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 85 |
Alpa Laboratories Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 86 |
Alpha Teknova Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 87 |
Alphamab Oncology (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 88 |
Alteogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 89 |
Alterity Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 90 |
Althaia SA Industria Farmaceutica (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 91 |
Althea Group Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 92 |
Altimmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 93 |
Alto Neuroscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 94 |
Alumis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 95 |
Alvogen Pharma US, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 96 |
ALX Oncology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 97 |
Alxndr Cmpy fr Phrmls nd Chcl ndstrs SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 98 |
Amarin Corporation PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 99 |
Ambalal Sarabhai Enterprises Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 100 |
America Great Health (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 101 |
American Cannabis Company Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 102 |
American Vietnamese Biotech Inc (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 103 |
Amgen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 104 |
Amicogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 105 |
Amicus Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 106 |
Aminologics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 107 |
Amneal Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 108 |
Amoy Diagnostics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 109 |
Amphastar Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 110 |
Amrutanjan Health Care Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 111 |
Amwill Health Care Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 112 |
Amylyx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 113 |
Anatara Lifesciences Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 114 |
Andon Health Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 115 |
Andros Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 116 |
ANG Lifesciences India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 117 |
Anhui Anke Biotechnology Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 118 |
Anhui Fengyuan Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 119 |
Anhui Heryi Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 120 |
Anhui Huaheng Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 121 |
Anhui Sunhere Pharmcl Excipients Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 122 |
ANI Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 123 |
Animalcare Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 124 |
Annexin Pharmaceuticals AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 125 |
Annexon Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 126 |
AnnJi Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 127 |
Anterogen Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 128 |
Antibiotice SA (Romania) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 129 |
Anuh Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 130 |
Anxo Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 131 |
Apellis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 132 |
Apeloa Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 133 |
Apex Biotechnology Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 134 |
ApicHope Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 135 |
Apollo 5 Gmbh (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 136 |
Apollo Ingredients Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 137 |
Apollomics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 138 |
Apontis Pharma AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 139 |
Appili Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 140 |
Applied DNA Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 141 |
AprilBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 142 |
Aprogen Biologics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 143 |
Aptahem AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 144 |
Aptevo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 145 |
Aptose Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 146 |
Aquestive Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 147 |
Arab Center for Pharmaceuticals & Chem (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 148 |
Arab Drug Cmpny fr Pharm nd Chem Ind SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 149 |
Arctic Bioscience AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 150 |
Arcticzymes Technologies ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 151 |
Arcus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 152 |
Arecor Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 153 |
Armata Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 154 |
Aroa Biosurgery Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 155 |
Arvinas Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 156 |
Ascend Wellness Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 157 |
Ascletis Pharma Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 158 |
ASKA Pharmaceutical Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 159 |
Aspen Pharmacare Holdings Ltd (South Africa) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 160 |
Aspira Women's Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 161 |
Assembly Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 162 |
Assertio Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 163 |
Assure Tech Hangzhou Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 164 |
Astal Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 165 |
Astellas Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 166 |
Astena Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 167 |
Astra Industrial Group Company SJSC (Saudi Arabia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 168 |
Astrazeneca Pharma India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 169 |
AstraZeneca plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 170 |
Asymchem Laboratories (Tianjin) Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 171 |
Atect Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 172 |
Athenex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 173 |
Atlas Global Brands Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 174 |
Aurisco Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 175 |
Auro Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 176 |
Aurobindo Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 177 |
Aurora Cannabis Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 178 |
Auscann Group Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 179 |
Autobio Diagnostics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 180 |
Auxly Cannabis Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 181 |
Avadel Pharmaceuticals PLC (ADR) (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 182 |
Avant Brands Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 183 |
AVE Science & Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 184 |
Avenir Wellness Solutions Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 185 |
Avid Bioservices Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 186 |
Avidity Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 187 |
Awakn Life Sciences Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 188 |
Axim Biotechnologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 189 |
Ayala Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 190 |
Ayr Wellness Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 191 |
Aytu Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 192 |
B.M.P. Pharma Trading AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 193 |
Bacil Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 194 |
Bafna Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 195 |
Bajaj Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 196 |
Bakhu Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 197 |
Bal Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 198 |
Bangkok Lab and Cosmetic PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 199 |
BaskhanBioPharma Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 200 |
Bausch Health Americas, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 201 |
Bausch Health Companies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 202 |
Bavarian Nordic A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 203 |
Baxalta Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 204 |
Bayer AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 205 |
Bayer Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 206 |
BCAL Diagnostics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 207 |
BCWorldPharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 208 |
BDH Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 209 |
Beacon Pharmaceuticals PLC (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 210 |
Beigene Ltd (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 211 |
Beijing Aosaikang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 212 |
Beijing Beilu Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 213 |
Beijing Biostar Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 214 |
Beijing Bohui Innovat Biotech Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 215 |
Beijing Centergate Technolgs Hldng C Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 216 |
Beijing Foyou Pharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 217 |
Beijing Health Guard Biotechnology Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 218 |
Beijing Hotgen Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 219 |
Beijing Kawin Technol Sha-hld Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 220 |
Beijing Konruns Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 221 |
Beijing Leadman Biochemistry Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 222 |
Beijing Luzhu Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 223 |
Beijing Science Sun Pharmaceutical CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 224 |
Beijing Scitop Bio-tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 225 |
Beijing SL Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 226 |
Beijing Strong Biotechnologies Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 227 |
Beijing Sunho Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 228 |
Beijing Tiantan Biological Products Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 229 |
Beijing Tong Ren Tang Chinese Medicine (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 230 |
Beijing Tong Ren Tang Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 231 |
Beijing Tri Prime Gene Pharmcutcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 232 |
Beijing Wantai Biolog Pha Ent Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 233 |
Beit Jala Pharma Manufacturing Co (Palestinian territories) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 234 |
Beryl Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 235 |
Bespoke Extracts Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 236 |
Betta Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 237 |
BetterLife Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 238 |
Beximco Pharmaceuticals Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 239 |
BF Biosciences Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 240 |
BGM Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 241 |
Bharat Parenterals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 242 |
Bicara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 243 |
Billions Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 244 |
Binex Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 245 |
Binh Dinh Pharmctcl & Medical Eqpmnt JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 246 |
Bio Plus Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 247 |
Bio Preventive Medicine Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 248 |
Bio Solution Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 249 |
Bio Vitos Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 250 |
Bio-FD&C Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 251 |
BIO-TECHNE Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 252 |
Bio-Thera Solutions Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 253 |
bioAffinity Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 254 |
BIOAGE Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 255 |
Bioalpha Holdings Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 256 |
Bioatla Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 257 |
BioCardia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 258 |
Bioceltix SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 259 |
Biocon Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 260 |
BioCryst Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 261 |
Biocytogen Pharmaceuticals Beijng Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 262 |
Biodyne Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 263 |
Biofarm SA (Romania) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 264 |
Biofil Chemicals and Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 265 |
Biofrontera AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 266 |
Biofrontera Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 267 |
BioGaia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 268 |
Biogen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 269 |
BIOGENED SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 270 |
Bioharvest Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 271 |
Biohaven Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 272 |
Biohit Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 273 |
BioInfra Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 274 |
Biokhimik AO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 275 |
Biomarin Pharmaceutical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 276 |
BioMaxima SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 277 |
Biome Australia Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 278 |
BioMerieux SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 279 |
BIONET Therapeutics Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 280 |
Bionime Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 281 |
BioNote Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 282 |
BioNxt Solutions Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 283 |
BioPorto A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 284 |
Bioray Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 285 |
Biosenic SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 286 |
BioSino Bio-technology and Science Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 287 |
Biosintez PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 288 |
Biostax Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 289 |
Biostem Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 290 |
Biosyent Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 291 |
Biosynex SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 292 |
Biotest AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 293 |
Biotika as (Slovakia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 294 |
BIOTON SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 295 |
BioVie Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 296 |
Birzeit Pharmaceutical Company Ltd (Palestinian territories) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 297 |
Blau Farmaceutica SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 298 |
BLIS Technologies Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 299 |
Bliss GVS Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 300 |
Bloomage Biotechnology Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 301 |
Blue Jet Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 302 |
Blue Wave Water Capital Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 303 |
Blueberries Medical Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 304 |
Blueprint Medicines Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 305 |
Bluestar Adisseo Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 306 |
BNC Korea Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 307 |
Bod Science Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 308 |
Body and Mind Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 309 |
Boiron SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 310 |
Bolt Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 311 |
Bonesupport Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 312 |
Bonraybio Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 313 |
Bora Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 314 |
Boryung Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 315 |
Bosnalijek d.d. Sarajevo (Bosnia and Herzegovina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 316 |
Botanix Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 317 |
Brainstorm Cell Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 318 |
Brawn Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 319 |
Braxia Scientific Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 320 |
Bridge Biotherapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 321 |
BridgeBio Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 322 |
Bright Green Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 323 |
BrightGene Bio-Medical Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 324 |
Brigit Biofarmaka Teknologi Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 325 |
Bristol-Myers Squibb Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 326 |
Britannia Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 327 |
Brooks Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 328 |
Brother Enterprises Holding Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 329 |
BSF Enterprise PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 330 |
Bukwang Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 331 |
Burzynski Research Institute Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 332 |
Byhealth Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 333 |
C&R Research Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 334 |
Cabio Biotech Wuhan Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 335 |
Cai Lay Veterinary Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 336 |
Calethos Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 337 |
Calidi Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 338 |
Calliditas Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 339 |
Calmer Co International Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 340 |
Calth Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 341 |
Cambium Bio Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 342 |
Cambrex Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 343 |
Cambridge Nutritional Sciences PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 344 |
Camurus AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 345 |
Can Fite Biopharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 346 |
CanadaBis Capital Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 347 |
Canbridge Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 348 |
Cann Group Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 349 |
Cannabis Poland SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 350 |
Cannara Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 351 |
Cannassieur Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 352 |
Cannibble Foodtech Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 353 |
Canopy Growth Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 354 |
Cansino Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 355 |
Cantourage Group SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 356 |
Caplin Point Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 357 |
Capricor Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 358 |
Cardiff Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 359 |
Caregen Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 360 |
CARsgen Therapeutics Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 361 |
CASI Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 362 |
Cassava Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 363 |
Castle Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 364 |
Catalent Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 365 |
Catalyst Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 366 |
cbdMD Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 367 |
CEL-SCI Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 368 |
Celadon Pharmaceuticals PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 369 |
Celestial Biolabs Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 370 |
Celestra Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 371 |
Cell Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 372 |
Cellbion Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 373 |
Celldex Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 374 |
Cellectar Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 375 |
Cellid Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 376 |
Celltrion Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 377 |
Celltrion Pharm Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 378 |
Cellumed Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 379 |
Celon Pharma SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 380 |
Celularity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 381 |
Cenra Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 382 |
Center Laboratories, Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 383 |
Central Pharmaceutical CPC1 JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 384 |
Central Pharmaceutical JSC No2 (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 385 |
Central Pharmaceutical JSC No3 (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 386 |
Cereno Scientific AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 387 |
CERo Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 388 |
Ceva Sante Animale SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 389 |
CG Invites Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 390 |
CHA Vaccine Research Institute (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 391 |
Champions Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 392 |
Chandra Bhagat Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 393 |
Changchun BCHT Biotechnology Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 394 |
Changchun High-Tech Industry Grop Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 395 |
Changjiang Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 396 |
Changzhou Qianhong Biopharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 397 |
Charlie's Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 398 |
Charlotte's Web Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 399 |
Cheil Bio Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 400 |
Chemclin Diagnostics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 401 |
Chemcrux Enterprises Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 402 |
Chemo Pharma Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 403 |
Chengda Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 404 |
Chengdu Easton Biopharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 405 |
Chengdu huasun technology group Inc Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 406 |
Chengdu Kanghong Pharma Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 407 |
Chengdu Kanghua Biological Prdcts Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 408 |
Chengdu Okay Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 409 |
Chengdu Olymvax Biopharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 410 |
ChengDu Sheng Nuo Biotec Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 411 |
Cheplapharm Arzneimittel GmbH (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 412 |
Chi Sheng Pharma & Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 413 |
Chimeric Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 414 |
China Animal Husbandry Industry Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 415 |
China Health Industries Holdings, Inc. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 416 |
China Isotope & Radiation Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 417 |
China Pharma Holdings Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 418 |
China Resources Dubl-Crne Phrmctl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 419 |
China Resources Sanju Mdcl & Phrm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 420 |
China Resrcs Boya Bio phrmctcl Grp CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 421 |
China Shineway Pharmaceutical Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 422 |
China SXT Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 423 |
China Traditional Chinese Med Hldg CoLtd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 424 |
CHO Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 425 |
ChoA Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 426 |
Chong Kun Dang Pharmaceutical Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 427 |
Chongkundang Holdings Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 428 |
Chongqing Genrix Biophrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 429 |
Chongqing Lummy Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 430 |
Chongqing Pharscin Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 431 |
Chongqing Taiji Industry Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 432 |
Chongqing Zhifei Biological Prdct Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 433 |
Choong Ang Vaccine Laboratory (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 434 |
Chosa Oncology AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 435 |
Chugai Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 436 |
Chunghwa Chemical Synthsis&Biotech CoLtd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 437 |
Cian Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 438 |
Cilo Cybin Holdings Ltd (South Africa) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 439 |
Cingulate Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 440 |
Cipher Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 441 |
Cipla Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 442 |
Circa Group AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 443 |
Cisen Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 444 |
Citi Pharma Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 445 |
City View Green Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 446 |
CK Life Sciences Intl (Holdings) Inc (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 447 |
CKD Bio Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 448 |
Clover Biopharmaceuticals Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 449 |
Clover Corporation Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 450 |
CMG Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 451 |
CMIC Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 452 |
CNBX Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 453 |
Cocrystal Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 454 |
Coegin Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 455 |
Coeptis Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 456 |
Cohance Lifesciences Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 457 |
Coherus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 458 |
Colinz Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 459 |
Collegium Pharmaceutical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 460 |
Comfar SAECA (Paraguay) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 461 |
Compugen Ltd (USA) (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 462 |
Concord Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 463 |
Concord Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 464 |
Consun Pharmaceutical Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 465 |
Contineum Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 466 |
Coral Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 467 |
Corbus Pharmaceuticals Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 468 |
Corcept Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 469 |
Cordyceps Sunshine Biotech Hldngs Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 470 |
Core One Labs Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 471 |
Corline Biomedical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 472 |
CorMedix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 473 |
COSCIENS Biopharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 474 |
Cosmax NBT Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 475 |
Cosmo Pharmaceuticals NV (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 476 |
Cresco Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 477 |
Crestchem Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 478 |
CRISM' Therapeutics Corp (British Virgin Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 479 |
Croda International Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 480 |
Cronos Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 481 |
CRUSHMETRIC Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 482 |
Csl LTD (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 483 |
CSPC Innovation Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 484 |
CSPC Pharmaceutical Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 485 |
CStone Pharmaceuticals (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 486 |
CTC Bio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 487 |
Cue Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 488 |
Cumberland Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 489 |
Cuorips Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 490 |
Cuprina Holdings (Cayman) Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 491 |
CuraChem Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 492 |
Curaleaf Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 493 |
Curanex Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 494 |
Curatis Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 495 |
Curia Global, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 496 |
Curis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 497 |
Curium BidCo S.a r.l. (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 498 |
Cutia Therapeutics (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 499 |
Cuu Long Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 500 |
CYANOTECH CORP (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 501 |
Cyclacel Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 502 |
Cyclo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 503 |
CytoDyn Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 504 |
Cytokinetics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 505 |
CytoMed Therapeutics Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 506 |
CytomX Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 507 |
Cytophage Technologies Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 508 |
Cyxone AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 509 |
Daan Gene Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 510 |
Dae Hwa Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 511 |
DaebongLS Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 512 |
Daehan Nupharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 513 |
Daesung Microbiological Labs, Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 514 |
Daewon Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 515 |
Daewoong Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 516 |
Daewoong Pharma (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 517 |
Dai Han Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 518 |
Daiichi Sankyo Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 519 |
Daito Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 520 |
Dali Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 521 |
Danapha Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 522 |
Dancann Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 523 |
Dar Al Dawa Dvlpmnt and Invstmnt Co PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 524 |
Dare Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 525 |
Darya-Varia Laboratoria Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 526 |
Dawnrays Pharmaceutical (Holdings) Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 527 |
Day One Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 528 |
DBV Technologies SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 529 |
Deccan Health Care Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 530 |
Dechra Pharmaceuticals Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 531 |
Decibel Cannabis Company Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 532 |
Decipher Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 533 |
Deciphera Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 534 |
Delivra Health Brands Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 535 |
Delta 9 Cannabis Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 536 |
Delta-Fly Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 537 |
Denis Chem Lab Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 538 |
Dermapharm Holding SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 539 |
Desh Rakshak Aushdhalaya Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 540 |
Design Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 541 |
Deva Holding AS (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 542 |
Devonian Health Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 543 |
Devyser Diagnostics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 544 |
Dezhan HealthCare Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 545 |
Dhg Pharmaceutical Joint-Stock Co (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 546 |
DiaSorin SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 547 |
Diod PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 548 |
Disc Medicine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 549 |
Dishman Carbogen Amcis Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 550 |
Divi's Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 551 |
Dizal Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 552 |
DOD Biotech PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 553 |
Domesco Medical Import Exprt Jnt Stk Crp (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 554 |
Dong-A Socio Holdings Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 555 |
Dong-A ST Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 556 |
Dong-E-E-Jiao Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 557 |
DongKoo Bio & Pharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 558 |
Dongkook Life Science Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 559 |
Dongkook Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 560 |
Dongsung Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 561 |
Dongwha Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 562 |
Doseology Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 563 |
Dottikon ES Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 564 |
Double Bond Phrmcutcl Intrntnl AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 565 |
Dr Reddy's Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 566 |
Duality Biotherapeutics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 567 |
Duchembio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 568 |
Duopharma Biotech Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 569 |
DuPont de Nemours Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 570 |
DURECT Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 571 |
Dx & Vx Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 572 |
Dynavax Technologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 573 |
Eagle Veterinary Technology Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 574 |
Earth Science Tech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 575 |
Eastwood Bio-Medical Canada Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 576 |
Easywell Biomedicals Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 577 |
Eco Animal Health Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 578 |
Ecofinity Atomix Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 579 |
Egetis Therapeutics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 580 |
Egyptian Interntnl Phrmcticl Inds Co SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 581 |
Eiken Chemical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 582 |
EirGenix Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 583 |
EIS czcbs lc Sn v Fnnsl Ytrmlr Sny v Tcr (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 584 |
Eisai Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 585 |
El Nile Cmpy for Pharma and Chem Ind SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 586 |
Elanco Animal Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 587 |
Eli Lilly and Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 588 |
Elicera Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 589 |
Elite Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 590 |
Elixinol Wellness Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 591 |
Elutia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 592 |
Elysium Pharmaceuticals Ltd. (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 593 |
Emcure Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 594 |
Emergent Biosolutions Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 595 |
Emmaus Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 596 |
Emmessar Biotech and Nutrition Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 597 |
Enanta Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 598 |
Endo Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 599 |
Endo International PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 600 |
Enlie Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 601 |
Enorama Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 602 |
Ensol Biosciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 603 |
Entero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 604 |
Entourage Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 605 |
Entrada Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 606 |
Enwei Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 607 |
Enzon Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 608 |
Enzychem Lifesciences Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 609 |
Enzymatica AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 610 |
Epigenomics AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 611 |
Epitomee Medical Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 612 |
EPS BIO TECHNOLOGY CORP (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 613 |
Epsilon Healthcare Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 614 |
EQL Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 615 |
Eris Lifesciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 616 |
Esperion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 617 |
Essex Bio-Technology Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 618 |
Estrella Immunopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 619 |
Eton Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 620 |
EuBiologics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 621 |
Eupraxia Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 622 |
Euro-Med Laboratories Phil Inc (Philippines) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 623 |
Euroapi SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 624 |
Eurobio Scientific SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 625 |
Eurofarma Laboratorios S.A. (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 626 |
Eurofarma Laboratorios SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 627 |
Eusol Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 628 |
Eutilex Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 629 |
Ever Supreme Bio Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 630 |
Everest Medicines Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 631 |
Everest Organics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 632 |
Evofem Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 633 |
Evoke Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 634 |
EVOQ Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 635 |
Evotec SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 636 |
ExpreS2ion Biotech Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 637 |
Exscientia PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 638 |
Extrawell Pharmaceutical Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 639 |
EyeGene Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 640 |
Eyenovia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 641 |
EZZ Life Science Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 642 |
F D C Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 643 |
F.I.S. Fabbrica Italiana Sintetici SPA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 644 |
Fabino Enterprises Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 645 |
FAES Farma SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 646 |
Fagron NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 647 |
Far East Bio Tec Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 648 |
Farmstandart-Tomskkhimfarm OAO (P) (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 649 |
Fate Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 650 |
Fennec Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 651 |
Fermenta Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 652 |
Ferozsons Laboratories Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 653 |
Fidson Healthcare PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 654 |
Filament Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 655 |
Fine Foods & Pharmaceuticals NTM SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 656 |
Firebrick Pharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 657 |
FitLife Brands Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 658 |
Flerie AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 659 |
Flora Growth Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 660 |
Fluent Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 661 |
Foghorn Therapeutics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 662 |
Forma Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 663 |
Formosa Laboratories Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 664 |
Formosa Pharmaceuticals Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 665 |
Forte Group Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 666 |
Fortress Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 667 |
Fredun Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 668 |
Fresh Tracks Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 669 |
Friulchem SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 670 |
Frontier Biotechnologies Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 671 |
Fuan Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 672 |
Fuji Pharma Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 673 |
Fujian Cosunter Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 674 |
Fusen Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 675 |
Fuso Pharmaceutical Industries Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 676 |
Fuss Brands Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 677 |
Future Medicine Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 678 |
FutureChem Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 679 |
G&E Herbal Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 680 |
Gabather AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 681 |
Galectin Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 682 |
Gan & Lee Pharmaceuticals (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 683 |
Ganga Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 684 |
Gansu Lngshnrngf Phrmutl Industry Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 685 |
GC Biopharma Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 686 |
Gelteq Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 687 |
Gemina Laboratories Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 688 |
Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 689 |
Gencurix Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 690 |
Gene One Life Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 691 |
GeneBioTech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 692 |
GeneDx Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 693 |
General Biologicals Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 694 |
GeneReach Biotechnology Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 695 |
Genfit SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 696 |
Genflow Biosciences PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 697 |
Genincode PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 698 |
Genix Pharmaceuticals Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 699 |
Gennex Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 700 |
Genomma Lab Internacional SAB de CV (Mexico) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 701 |
Genotech Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 702 |
Genovate Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 703 |
Genovis AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 704 |
Genpharmasec Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 705 |
Gentian Diagnostics ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 706 |
Geron Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 707 |
Getein Biotech Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 708 |
Gilead Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 709 |
Gin Hwa Biotech Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 710 |
Ginwa Enterprise Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 711 |
Gland Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 712 |
GlaxoSmithKline LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 713 |
GlaxoSmithKline Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 714 |
GlaxoSmithKline Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 715 |
GlaxoSmithKline SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 716 |
Glenmark Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 717 |
Global Hemp Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 718 |
GlobeStar Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 719 |
Godavari Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 720 |
Golden Throat Holdings Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 721 |
Grand Pharmaceutical Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 722 |
Granules India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 723 |
Grape King Bio Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 724 |
Greater Cannabis Company Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 725 |
Green Cross Holdings (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 726 |
Green Cross Medical Science Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 727 |
Green Cross WellBeing Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 728 |
Green LifeScience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 729 |
Green Planet Bioengineering Co Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 730 |
Green Thumb Industries Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 731 |
Greenfern Industries Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 732 |
Greenrise Global Brands Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 733 |
Greenway Greenhouse Cannabis Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 734 |
Greenyn Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 735 |
Grey Wolf Animal Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 736 |
Grifols SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 737 |
Gritstone bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 738 |
Groupe Berkem SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 739 |
Grunenthal Pharma GmbH & Co. KG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 740 |
GSK plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 741 |
GT Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 742 |
Guangdong Hybribio Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 743 |
Guangdong Jiaying Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 744 |
Guangdong Lifestrong Pharmacy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 745 |
Guangdong Taiantang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 746 |
Guangdong Taienkang Pharmaceut Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 747 |
Guangdong VTR Bio-Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 748 |
Guangdong Winsun Bio-Phrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 749 |
Guangdong Zhongsheng Pharmaceutcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 750 |
Guangxi Wuzhou Zhongheng Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 751 |
GuangYuYuan Chinese Herbal Medicn Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 752 |
Guangzhou LBP Medicine Scnc&Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 753 |
Guangzhou Wondfo Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 754 |
Guardion Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 755 |
Guerbet SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 756 |
Gufic BioSciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 757 |
Guilin Sanjin Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 758 |
Guiyang Xintian Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 759 |
Guizhou Bailing Grp Phrmctcl C Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 760 |
Guizhou Sanli Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 761 |
Guizhou Xinbang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 762 |
GuiZhou YiBai Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 763 |
Gujarat Terce Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 764 |
Gujarat Themis Biosyn Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 765 |
Gulf Pharmaceutcl Indtrs Julphar Co PJSC (United Arab Emirates) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 766 |
Guobang Pharma Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 767 |
Gwo Xi Stem Cell Applied Technlgy Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 768 |
Gyre Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 769 |
H Lundbeck A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 770 |
H PIO Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 771 |
Ha Noi CPC1 Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 772 |
Hai Duong Pharmaceutical Medical Mat JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 773 |
Hainan Haiyao Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 774 |
Hainan Huluwa Pharmaceutical Grop Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 775 |
Hainan Poly Pharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 776 |
Hainan Shuangcheng Phrmcutcls Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 777 |
Haisco Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 778 |
Haleon Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 779 |
HALEON PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 780 |
Halozyme Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 781 |
Hana Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 782 |
Hanall Biopharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 783 |
Handa Pharmaceuticals Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 784 |
Handok Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 785 |
Hangzhou Alltest Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 786 |
Hangzhou Biotest Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 787 |
Hangzhou Jiuyuan Genetic Biopharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 788 |
Hangzhou Minsheng Healthcare Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 789 |
Hangzhou Tianmushan Phrmtcl ntrprs C Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 790 |
Hanmi Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 791 |
Hanshang Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 792 |
Hansoh Pharmaceutical Group Company Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 793 |
Harbin Gloria Pharmaceuticals Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 794 |
Harbin Medisan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 795 |
Harbin Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 796 |
Harbor Diversified Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 797 |
Harmony Biosciences Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 798 |
Harrow Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 799 |
Hatay Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 800 |
Hatinh Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 801 |
Haw Par Corporation Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 802 |
Hayat Pharmaceutical Industries Comp PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 803 |
Hbm Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 804 |
Healthy Extracts Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 805 |
Hebei Changshan Biochemical Pharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 806 |
Heilongjiang ZBD Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 807 |
Helixmith Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 808 |
Hempalta Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 809 |
Hempnova Lifetech Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 810 |
Henan Lingrui Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 811 |
Henan Taloph Pharmaceutical Stock Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 812 |
Herbs Generation Group Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 813 |
Heron Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 814 |
Heska Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 815 |
Hester Biosciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 816 |
HeXun Biosciences Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 817 |
High Tech Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 818 |
Highnoon Laboratories Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 819 |
Hikal Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 820 |
Hikma Pharmaceuticals Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 821 |
Hill Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 822 |
Hillestad Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 823 |
Hims & Hers Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 824 |
Hin Sang Group (Interntnl) Hldng Co Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 825 |
Hindustan Bio Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 826 |
Hinova Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 827 |
Hisamitsu Pharmaceutical Co Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 828 |
HK Inno.N Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 829 |
HL Science Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 830 |
HLB Genex Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 831 |
HLB Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 832 |
HLB PanaGene Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 833 |
HLB Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 834 |
HOB Biotech Group Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 835 |
Hoechst Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 836 |
Holy Stone Healthcare Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 837 |
Honz Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 838 |
Hookipa Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 839 |
Hoth Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 840 |
Huakang Biomedical Holdings Co Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 841 |
Hualan Biological Engineering Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 842 |
Hualan Biological Vaccine Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 843 |
Huapont Life Sciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 844 |
Huaren Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 845 |
Hubei Biocause Heilen Pharmacetcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 846 |
Hubei Goto Biopharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 847 |
Hubei Guangji Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 848 |
Hubei Hongyuan Pharmcutcl Tchnlgy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 849 |
Hubei Jumpcan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 850 |
Hugel Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 851 |
Humacyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 852 |
Humanwell Healthcare Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 853 |
Humasis Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 854 |
Humedix Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 855 |
Hunan ER-KANG Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 856 |
Hunan Fangsheng Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 857 |
Hunan Hansen Pharmaceutical Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 858 |
Hunan Jingfeng Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 859 |
Hunan Jiudian Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 860 |
Hunan Nucien Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 861 |
Hunan Warrant Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 862 |
Huons Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 863 |
Huons Global Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 864 |
HUTCHMED (China) Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 865 |
Hwail Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 866 |
Hybio Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 867 |
Hydration Pharmaceuticals Co Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 868 |
Hyloris Pharmaceuticals SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 869 |
Hypera SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 870 |
HYTN Innovations Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 871 |
Hyundai Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 872 |
I-Mab ADR (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 873 |
Ibn Sina Pharmaceutical Industry PLC (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 874 |
Icure Pharmaceutical Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 875 |
Ideaya Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 876 |
Identa Corp. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 877 |
IDEXX Laboratories Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 878 |
Idna Genomics Public Ltd (Cyprus) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 879 |
Idorsia Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 880 |
IGM Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 881 |
Ikapharmindo Putramas Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 882 |
Ikonisys SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 883 |
Il Dong Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 884 |
Ildong Holdings Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 885 |
Ilsung IS Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 886 |
Ilyang Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 887 |
Imagion Biosystems Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 888 |
Imexpharm Corp (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 889 |
ImmuCell Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 890 |
ImmuneOnco Biopharmaceuticls Shanghi Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 891 |
Immuno-Biological Laboratories Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 892 |
Immunocore Holdings PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 893 |
Immunome Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 894 |
Immunoprecise Antibodies Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 895 |
Immuron Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 896 |
Impact Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 897 |
Imunon Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 898 |
Incannex Healthcare Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 899 |
IND Swift Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 900 |
Ind Swift Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 901 |
Indiva Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 902 |
Indivior PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 903 |
Indoco Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 904 |
Indofarma Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 905 |
Indoor Harvest Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 906 |
Industri Jamu dn Frms Sd Mncl Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 907 |
Infant Bacterial Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 908 |
Infund Holding Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 909 |
InMed Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 910 |
Innate Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 911 |
Inner Mongolia Grand Pharmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 912 |
Innocan Pharma Corp (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 913 |
InnoCare Pharma Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 914 |
Innopharmax Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 915 |
Innova Captab Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 916 |
Innovent Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 917 |
Innovita Biological Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 918 |
Innoviva Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 919 |
Inoviq Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 920 |
Insmed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 921 |
Integrated Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 922 |
IntelGenx Technologies Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 923 |
Inter Pharma PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 924 |
Intercept Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 925 |
InterCure Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 926 |
International Stem Cell Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 927 |
Intervacc AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 928 |
Intra-Cellular Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 929 |
iNtRON Biotechnology Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 930 |
Inventage Lab Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 931 |
Invivyd Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 932 |
Ionis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 933 |
IPCA Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 934 |
Ipsen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 935 |
IRLAB Therapeutics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 936 |
Ironwood Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 937 |
Ishita Drugs and Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 938 |
Isofol Medical AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 939 |
Isu Abxis Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 940 |
IX Biopharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 941 |
J B Chemicals and Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 942 |
J2KBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 943 |
Jack Chia Industries Thailand PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 944 |
Jacobson Pharma Corporation Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 945 |
Jagsonpal Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 946 |
Jaguar Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 947 |
Jamieson Wellness Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 948 |
Jamjoom Pharmaceuticals Fctry Cmpny SJSC (Saudi Arabia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 949 |
Jazz Pharmaceuticals PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 950 |
Jbm (Healthcare) Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 951 |
JCR Pharmaceuticals Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 952 |
Jeil Pharma Holdings Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 953 |
Jeil Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 954 |
Jenburkt Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 955 |
Jerusalem Pharmaceuticals Co Ltd (Palestinian territories) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 956 |
Jetema Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 957 |
Ji Yao Holding Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 958 |
Jiang Zhong Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 959 |
Jiangsu Aidea Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 960 |
Jiangsu Bioperfectus Technologies Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 961 |
Jiangsu Cowin Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 962 |
Jiangsu Deyuan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 963 |
Jiangsu gdk Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 964 |
Jiangsu Hengrui Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 965 |
Jiangsu Jibeier Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 966 |
Jiangsu Kanion Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 967 |
Jiangsu Recbio Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 968 |
Jiangsu Senxuan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 969 |
Jiangsu Sihuan Bioengineering Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 970 |
Jiangsu Sinopep Allsin Bphrmctcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 971 |
JiangSu WuZhong Pharmactcl Devlpm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 972 |
Jiangxi Fushine Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 973 |
Jiangxi Synergy Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 974 |
Jiangxi Tianxin Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 975 |
Jiangxi Xinganjiang Pharmaceutical Co Ld (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 976 |
Jianmin Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 977 |
Jilin Aodong Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 978 |
Jilin Jian Yisheng Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 979 |
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 980 |
Jilin Prvnc Xdn Phmtc Sc-Tch Dvlt Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 981 |
Jin Yang Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 982 |
Jinan High-tech Development Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 983 |
Jinghua Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 984 |
Jinhe Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 985 |
Jinling Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 986 |
Jinyao Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 987 |
Jinyu Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 988 |
Jiuzhitang Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 989 |
JMolner AS (Estonia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 990 |
Johnson & Johnson (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 991 |
Johnson Chemical Pharmactcl Works Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 992 |
Joincare Pharmaceutical Group Ind. Co. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 993 |
Jolt Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 994 |
Jordanian Pharmaceutical Mnfctrng C PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 995 |
Journey Medical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 996 |
JSP Pharmactcl Mnfctrng (Thailand) PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 997 |
Jubilant Pharmova Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 998 |
Jushi Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 999 |
JW Holdings Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,000 |
JW Life Science Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,001 |
JW Pharmaceutical Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,002 |
JW Shinyak Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,003 |
K Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,004 |
Kahira Pharmaceuticals & Chmcl Indtrs Co (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,005 |
KaiBioTech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,006 |
Kainos Laboratories Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,007 |
Kaken Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,008 |
Kalbe Farma Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,009 |
Kaleido Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,010 |
Kamada Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,011 |
Kanabo Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,012 |
Kancera AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,013 |
Kane Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,014 |
Kangmei Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,015 |
Karyopharm Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,016 |
Katakura Industries Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,017 |
Kaya Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,018 |
Kedrion SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,019 |
Kexing Biopharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,020 |
Keymed Biosciences Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,021 |
Kilitch Drugs (India) Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,022 |
Kimia Biosciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,023 |
Kingchem Liaoning Life Science Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,024 |
Kiniksa Pharmaceuticals Internationl PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,025 |
Kissei Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,026 |
Klotho Neurosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,027 |
Knight Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,028 |
Koa Shoji Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,029 |
Kobayashi Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,030 |
KoBioLabs Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,031 |
KOBO Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,032 |
Koei Chemical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,033 |
Kohjin Bio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,034 |
KolmarBNH Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,035 |
KOLON LIFE SCIENCE INC. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,036 |
Komipharm International Co., Ltd. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,037 |
Kontafarma China Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,038 |
Kopran Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,039 |
Korea Arlico Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,040 |
Korea Pharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,041 |
KOREA UNITED PHARM INC (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,042 |
Korean Drug Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,043 |
Kotra Industries Berhad (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,044 |
KPC Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,045 |
Krasfarma PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,046 |
Krebs Biochemicals And Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,047 |
Krka dd Novo Mesto (Slovenia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,048 |
Kubota Pharmaceutical Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,049 |
Kukje Pharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,050 |
Kukjeon Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,051 |
Kunming Longjin Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,052 |
Kura Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,053 |
Kwality Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,054 |
Kyongbo Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,055 |
Kyorin Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,056 |
Kyowa Kirin Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,057 |
Kyung Dong Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,058 |
Kyung Nam Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,059 |
Labiana Health SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,060 |
Laboratorio Farmaceutico Erfo SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,061 |
Laboratorio Reig Jofre SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,062 |
Laboratorios Farmaceuticos ROVI SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,063 |
Laboratorios Richmond SACIF (Argentina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,064 |
LadRx Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,065 |
LakeShore Biopharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,066 |
Lannett Company, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,067 |
Lanzhou Foci Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,068 |
Lasa Supergenerics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,069 |
Launxp Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,070 |
Laurus Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,071 |
Lavipharm SA (Greece) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,072 |
Lee's Pharmaceutical Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,073 |
Leef Brands Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,074 |
LEO Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,075 |
Lepu Biopharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,076 |
Lexaria Bioscience Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,077 |
Lexicon Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,078 |
Liaoning Cheng Da Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,079 |
Liaoning Chengda Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,080 |
Lifecome Biochemistry Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,081 |
Lifeist Wellness Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,082 |
LifeVantage Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,083 |
Ligand Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,084 |
Limitless X Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,085 |
Lin Bioscience Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,086 |
Lincoln Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,087 |
Lineage Cell Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,088 |
Link Pharmachem Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,089 |
Lionco Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,090 |
Lipidor AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,091 |
Lipigon Pharmaceuticals AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,092 |
Little Green Pharma Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,093 |
Liven Pharma Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,094 |
Livzon Pharmaceutical Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,095 |
Lixte Biotechnology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,096 |
Lobe Sciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,097 |
Lonza Group AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,098 |
Lotus Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,099 |
Lowell Farms Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,100 |
LSL Pharma Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,101 |
Lucy Scientific Discovery Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,102 |
Lumos Diagnostics Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,103 |
Lumos Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,104 |
Luoxin Pharmaceuticals Group Stock CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,105 |
Lupin Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,106 |
Lushang Freda Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,107 |
Luye Pharma Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,108 |
Lyka Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,109 |
Mabpharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,110 |
Mabwell Shanghai Bioscience Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,111 |
Maccura Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,112 |
Macro Group Pharmaceutical SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,113 |
Macter International Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,114 |
Magle Chemoswed Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,115 |
Magnasense AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,116 |
Mainz Biomed NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,117 |
Makers Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,118 |
Malin Corporation plc (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,119 |
Mallinckrodt PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/27/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,120 |
Mangalam Drugs and Organics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,121 |
Mangoceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,122 |
Mankind Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,123 |
Mannatech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,124 |
MannKind Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,125 |
Maple Leaf Green World Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,126 |
Maravai Lifesciences Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,127 |
Marimed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,128 |
Marinomed Biotech AG (Austria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,129 |
Marizyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,130 |
Marker Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,131 |
Marksans Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,132 |
Marocaine Ste de Therapeutique SA (Morocco) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,133 |
Marvel Biosciences Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,134 |
MaxCyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,135 |
May & Baker Nigeria PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,136 |
Mayinglong Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,137 |
Mayne Pharma Group Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,138 |
MDxHealth SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,139 |
ME Therapeutics Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,140 |
Mecure Industries PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,141 |
Medexus Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,142 |
Median Diagnostics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,143 |
MedicalSystem Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,144 |
Medicamen Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,145 |
Medicamen Organics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,146 |
Medicinova Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,147 |
Medico Intercontinental Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,148 |
Medico Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,149 |
Medicus Pharma Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,150 |
Medigen Vaccine Biologics Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,151 |
Medincell SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,152 |
Medipharco Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,153 |
Medipharm Labs Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,154 |
Mediplantex National Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,155 |
Meditrina Cyprus PLC (Cyprus) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,156 |
Mediwound Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,157 |
Medy Tox Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,158 |
Mega Lifesciences PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,159 |
Megasoft Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,160 |
MEI Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,161 |
MeiraGTx Holdings PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,162 |
Mekophar Chemical Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,163 |
Melodiol Global Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,164 |
Memphis Pharmaceuticals&Chem Inds SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,165 |
Mendell Helium PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,166 |
Mercanto Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,167 |
Merck & Co Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,168 |
Merck KGaA (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,169 |
Merck Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,170 |
Mercury Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,171 |
Merdury Biopharmaceutical Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,172 |
Mereo BioPharma Group plc - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,173 |
Merrimack Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,174 |
Metagenomi Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,175 |
MetrioPharm AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,176 |
MFC Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,177 |
Microbot Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,178 |
MicroPort NeuroScientic Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,179 |
Middle East Pharmaceutical Inds Co SJSC (Saudi Arabia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,180 |
Middle East Pharmactl&Chem Inds&Med PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,181 |
Minapharm Pharmaceuticals SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,182 |
MindBio Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,183 |
Minerva Neurosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,184 |
Mirum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,185 |
Mithra Pharmaceuticals SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,186 |
Mizuho Medy Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,187 |
Moa Life Plus (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,188 |
Moberg Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,189 |
Mochida Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,190 |
Modern Chinese Medicine Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,191 |
Modular Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,192 |
Molecular Templates Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,193 |
Mono Pharmacare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,194 |
MoonLake Immunotherapeutics (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,195 |
Morepen Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,196 |
Morning Light Co Ltd (Mauritius) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,197 |
Moss Genomics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,198 |
Mountain Valley MD Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,199 |
MPH Health Care AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,200 |
MTL Cannabis Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,201 |
Muromachi Chemicals Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,202 |
Mycenax Biotech Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,203 |
Mylan, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,204 |
MYND Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,205 |
Myriad Genetics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,206 |
Myungmoon Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,207 |
N0 25 Central Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,208 |
Nam Duoc JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,209 |
Nang Kuang Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,210 |
Nanjing Hicin Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,211 |
Nanjing King-Frind Bchmcl Phrmctcl C Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,212 |
Nanjing Vazyme Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,213 |
Nanoform Finland Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,214 |
NanoRepro AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,215 |
Nanosphere Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,216 |
Natac Natural Ingredients SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,217 |
Natco Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,218 |
Natural Alternatives International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,219 |
Natural Capsules Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,220 |
Nature's Sunshine Products Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,221 |
NatureWise Biotech & Medicals Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,222 |
Navana Pharmaceuticals PLC (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,223 |
Navco Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,224 |
Navetco National Veterinary JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,225 |
Nectar Lifesciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,226 |
Neimeth International Pharmaceuticls PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,227 |
Nektar Therapeutics (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,228 |
Neogen Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,229 |
Neopharmed Gentili SPA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,230 |
Neptune Wellness Solutions Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,231 |
NervGen Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,232 |
Neuland Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,233 |
Neuren Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,234 |
Neurizon Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,235 |
Neurocrine Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,236 |
Neutra Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,237 |
New Nordic Healthbrands AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,238 |
NewAmsterdam Pharma Company NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,239 |
Newbury Pharmaceuticals AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,240 |
Newland Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,241 |
NewTree Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,242 |
Nextleaf Solutions Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,243 |
NGeneBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,244 |
Ngl Fine Chem Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,245 |
Nha Trang Vccns nd Blgcl Prdcts JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,246 |
Niagen Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,247 |
Nibec Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,248 |
NicOx SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,249 |
Ningbo Menovo Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,250 |
Niox Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,251 |
Nippon Chemiphar Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,252 |
Nippon Shinyaku Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,253 |
Nkarta Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,254 |
NKGen Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,255 |
Norris Medicines Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,256 |
Nortec Quimica SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,257 |
North China Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,258 |
Northeast Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,259 |
Nova Consumer Group JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,260 |
Nova Organic PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,261 |
Nova Wellness Group Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,262 |
NovaBay Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,263 |
Novartis AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,264 |
Novartis Finance Corp. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,265 |
Novavax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,266 |
NovMetaPharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,267 |
Novo Nordisk A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,268 |
Novocure Ltd (Jersey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,269 |
Novoprotein Scientific Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,270 |
NS Wind Down Co Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,271 |
Nuformix PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,272 |
Nurix Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,273 |
NUTEX Befektetesi Nyrt (Hungary) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,274 |
Nutricircle Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,275 |
Nxera Pharma Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,276 |
Nymox Pharmaceutical Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,277 |
Nyrada Inc (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,278 |
Obio Technology Shanghai Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,279 |
Ocean Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,280 |
Octapharma AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,281 |
October Pharma For Pharmctcl Indstrs SAE (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,282 |
Ocugen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,283 |
Ocular Therapeutix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,284 |
Ocumension Therapeutics (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,285 |
Odi Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,286 |
Ohki Healthcare Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,287 |
OK Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,288 |
OliPass Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,289 |
Omeros Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,290 |
Omkar Pharmachem Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,291 |
Oncimmune Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,292 |
OncoCyte Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,293 |
Oncodesign Precision Medicine Opm SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,294 |
Oncolytics Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,295 |
Onconetix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,296 |
Oncopeptides AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,297 |
Oncorus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,298 |
Oncosil Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,299 |
Oncotelic Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,300 |
Oncozenge AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,301 |
Oncternal Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,302 |
Oneness Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,303 |
Onesano SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,304 |
Ono Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,305 |
Onyx Biotec Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,306 |
OPC Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,307 |
OPKO Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,308 |
Optimi Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,309 |
OptiNose Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,310 |
Optipharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,311 |
Optus Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,312 |
Opus Genetics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,313 |
Oragenics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,314 |
Oramed Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,315 |
Orchid Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,316 |
Orexo AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,317 |
Organigram Global Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,318 |
Organika AO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,319 |
Organogenesis Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,320 |
Organon & Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,321 |
Organon Pharma Indonesia Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,322 |
Orient Pharma Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,323 |
Orion Infusion Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,324 |
Orion Nutraceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,325 |
Orion Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,326 |
Orion Pharma Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,327 |
Ortin Global Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,328 |
Oruka Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,329 |
Oscotec Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,330 |
Otsuka Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,331 |
Otsuka Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,332 |
Ourofino SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,333 |
Oxford Biodynamics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,334 |
Oxford Cannabinoid Tchnlgs Hldngs PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,335 |
Oxygenta Pharmaceutical Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,336 |
Ozon Farmatsevtika PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,337 |
Pacific Shuanglin Bio-pharmacy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,338 |
Pacira Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,339 |
PainReform Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,340 |
Pak Fah Yeow International Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,341 |
Palatin Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,342 |
Palvella Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,343 |
Panacea Biotec Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,344 |
Panacea Life Sciences Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,345 |
Panbela Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,346 |
Panchsheel Organics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,347 |
Panion & BF Biotech Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,348 |
Panjon Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,349 |
Papa Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,350 |
Par Drugs and Chemicals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,351 |
Paranovus Entertainment Technology Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,352 |
Park Ha Biological Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,353 |
Parnax Lab Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,354 |
PCL INC (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,355 |
PDL BioPharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,356 |
Pentixapharm Holding AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,357 |
Peoplebio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,358 |
Peptron Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,359 |
Perrigo Company PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,360 |
Perrigo Finance Unlimited Company (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,361 |
Perseus Proteomics Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,362 |
Pet Pharm Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,363 |
PetIQ Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,364 |
Petro Usa Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,365 |
Pfizer Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,366 |
Pfizer Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,367 |
Phaarmasia Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,368 |
Phapros Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,369 |
Pharbaco Central Pharmaceutical No1 JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,370 |
Pharma Foods International Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,371 |
Pharmacia Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,372 |
Pharmacielo Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,373 |
Pharmacyte Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,374 |
PharmaEssentia Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,375 |
Pharmaids Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,376 |
Pharmala Biotech Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,377 |
Pharmanutra SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,378 |
PharmaResearch Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,379 |
Pharmaron Beijing Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,380 |
PharmaSGP Holding SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,381 |
Pharmather Holdings Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,382 |
Pharmedic Pharmaceutical Medicinal JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,383 |
Pharmesis International Ltd. (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,384 |
PharmGen Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,385 |
Pharmicell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,386 |
Pharming Group NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,387 |
Pharmosa Biopharm Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,388 |
Pharmsville Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,389 |
Pharos iBio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,390 |
Phaxiam Therapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,391 |
Phibro Animal Health Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,392 |
Philadelphia Pharmaceuticals Indu Co PSC (Jordan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,393 |
Phong Phu Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,394 |
Photocure ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,395 |
Pila Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,396 |
Pineapple Express Cannabis Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,397 |
Pioneer Green Farms Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,398 |
Piramal Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,399 |
PL Developments, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,400 |
Pliant Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,401 |
Plumbline Life Sciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,402 |
Pluri Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,403 |
PMV Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,404 |
Polaris AI Pharma Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,405 |
Polypeptide Group AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,406 |
Polypid Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,407 |
Porton Pharma Solutions Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,408 |
Prebona AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,409 |
Precigen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,410 |
Precision Biosensor Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,411 |
Precision Medicine Group, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,412 |
Prescient Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,413 |
Prestige Biologics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,414 |
Prestige Consumer Healthcare Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,415 |
Preveceutical Medical Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,416 |
Probi AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,417 |
Probiotec Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,418 |
Probiotix Health PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,419 |
Procter & Gamble Health Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,420 |
Procyon Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,421 |
Progen Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,422 |
Promino Nutritional Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,423 |
Propanc Biopharma Inc (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,424 |
ProPhase Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,425 |
Prostatype Genomics AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,426 |
Protalix Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,427 |
Proteome Sciences plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,428 |
Prothena Corporation PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,429 |
Protia Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,430 |
ProtoKinetix, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,431 |
Provectus Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,432 |
Provexis plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,433 |
Psyched Wellness Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,434 |
Psyence Biomedical Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,435 |
PTC Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,436 |
Pulike Biological Engineering Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,437 |
Puma Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,438 |
PuraPharm Corp Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,439 |
Purple Biotech Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,440 |
Pyridam Farma Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,441 |
Pyxis Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,442 |
PZ Cormay SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,443 |
Q32 Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,444 |
Qiagen NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,445 |
Qianjiang Yongan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,446 |
Qingdao Vland Biotech INC (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,447 |
Qinghai Spring Medicinl Rsrcs Tech CoLTD (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,448 |
Qomel Co (Saudi Arabia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,449 |
Quality Chemical Industries Ltd (Uganda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,450 |
QuantaMatrix Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,451 |
Quest Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,452 |
QUIA PHARMA AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,453 |
Quidelortho Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/30/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,454 |
Quratis Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,455 |
Radiopharm Theranostics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,456 |
Raphas Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,457 |
Reber Genetics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,458 |
Recce Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,459 |
Recordati Industria Chmc Frmctc SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,460 |
RedHill Biopharma Ltd (ADR) (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,461 |
Redwood Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,462 |
Regen BioPharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,463 |
Regenerative Medical Technology Grop Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,464 |
Regenerex Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,465 |
Regeneron Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,466 |
Regent Pacific Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,467 |
Relay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,468 |
Reliv International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,469 |
Remedium Lifecare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,470 |
RemeGen Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,471 |
Remus Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,472 |
Renascience Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,473 |
Renata PLC (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,474 |
Renhe Pharmacy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,475 |
Replek AD Skopje (Republic of North Macedonia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,476 |
Repligen Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,477 |
ReproCell Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,478 |
Respiratorius AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,479 |
REST EZ Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,480 |
Revance Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,481 |
Reyon Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,482 |
Rezolute Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,483 |
Rhythm Biosciences Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,484 |
Rhythm Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,485 |
Richter Gedeon Vegyeszeti Gyar Nyrt (Hungary) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,486 |
Rigel Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,487 |
RIV Capital Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,488 |
Rize Oncology Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,489 |
Roche Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,490 |
Roche Holdings, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,491 |
Rohto Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,492 |
Roopa Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,493 |
RP Bio lnc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,494 |
RPG Life Sciences Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,495 |
RTA Lbrtvrlr Byljk rnlr lc v Mkn Sny Tcr (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,496 |
Rua Bioscience Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,497 |
Rubicon Organics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,498 |
S Biomedics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,499 |
Sabaa Intrntl Co for Phrmtcl & Chmcl Ind (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,500 |
SAGE Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,501 |
Sagimet Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,502 |
Sagittarius Life Science Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,503 |
Sai Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,504 |
Sakar Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,505 |
Salarius Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,506 |
Sam Chun Dang Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,507 |
Sam-A Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,508 |
Samil Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,509 |
Samjin Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,510 |
Samrat Pharmachem Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,511 |
Samsung Biologics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,512 |
Samsung Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,513 |
Sanai Health Industry Group Co Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,514 |
Sandoz Group AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,515 |
Sandu Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,516 |
Sangamo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,517 |
Sanjivani Paranteral Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,518 |
Sanofi Consumer Healthcare India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,519 |
Sanofi India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,520 |
Sanofi SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,521 |
Sansure Biotech Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,522 |
Santen Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,523 |
Santhera Pharmaceuticals Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,524 |
Sarepta Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,525 |
Sat Kartar Shopping Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,526 |
Saudi Pht Ind nd Mdl Apl Crp SPM ADW SJS (Saudi Arabia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,527 |
Savara Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,528 |
Savior Lifetec Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,529 |
Sawai Group Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,530 |
Scandion Oncology A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,531 |
SCI Pharmtech Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,532 |
SciClone Pharmaceuticals (Holdings) Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,533 |
Science in Sport PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,534 |
Scilex Holding Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,535 |
ScinoPharm Taiwan Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,536 |
Scisparc Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,537 |
SCL Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,538 |
Scorpius Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,539 |
Scpharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,540 |
SCYNEXIS Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,541 |
Searle Company Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,542 |
Seegene Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,543 |
Seelos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,544 |
Seikagaku Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,545 |
Sellas Life Sciences Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,546 |
Senores Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,547 |
Seoul Pharma Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,548 |
Septerna Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,549 |
SeQuent Scientific Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,550 |
Serina Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,551 |
Shaanxi Kanghui Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,552 |
Shaanxi Panlong Phrmctcl Gp Ld By Shr Ld (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,553 |
Shamrock Industrial Company Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,554 |
Shandong Boan Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,555 |
Shandong Boyuan Pharmctcl & Chmcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,556 |
Shandong Buchang Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,557 |
Shandong Jincheng Pharmacetcl Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,558 |
Shandong Keyuan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,559 |
Shandong Lukang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,560 |
Shandong Oriental Ocean Sci-Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,561 |
Shandong Sinobioway Biomedicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,562 |
Shandong Sito Bio-technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,563 |
Shandong WIT Dyne Health Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,564 |
Shandong Wohua Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,565 |
Shandong Xinhua Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,566 |
Shanghai Allist Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,567 |
Shanghai Fosun Pharmaceutical (Group) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,568 |
Shanghai Fudan Forward S&T Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,569 |
Shanghai Fudan-Zhangjiang Bio-Pharm. Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,570 |
Shanghai Haixin Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,571 |
Shanghai Haoyuan Chemexpress Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,572 |
Shanghai Henlius Biotech Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,573 |
Shanghai Hile Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,574 |
Shanghai Junshi Biosciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,575 |
Shanghai Kaibao Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,576 |
Shanghai Kehua Bio-Engineering Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,577 |
Shanghai Labway Clinical Lab Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,578 |
Shanghai MicuRx Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,579 |
Shanghai OPM Biosciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,580 |
Shanghai RAAS Blood Products Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,581 |
Shanghai Rendu Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,582 |
Shanghai Rightongene Biotechnlgy Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,583 |
Shanghai Runda Medical Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,584 |
Shanghai Serum Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,585 |
Shanghai Shen Lian Biomedical Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,586 |
Shanghai Shenqi Pharmactcl Inv Mgt CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,587 |
Shanghai Shyndec Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,588 |
Shanghai Xiao Fang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,589 |
Shanghai Yizhong Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,590 |
Shanghai ZJ Bio-Tech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,591 |
Shanxi C&Y Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,592 |
Shanxi Zhendong Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,593 |
Shedir Pharma Srl Unipersonale (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,594 |
Shelter Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,595 |
Shenyang Xingqi Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,596 |
Shenzhen Bioeasy Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,597 |
Shenzhen Chipscreen Biosciences Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,598 |
Shenzhen Hepalink Pharma Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,599 |
Shenzhen Kangtai Biological Prods Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,600 |
Shenzhen Neptunus Intrlng Bi tchnq CoLtd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,601 |
Shenzhen New Industries Bmdcl Eng Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,602 |
Shenzhen Salubris Pharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,603 |
Shenzhen Weiguang Biologcl Prdcts Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,604 |
Shijiazhuang Yiling Pharmaceuticl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,605 |
Shilpa Medicare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,606 |
Shineco Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,607 |
Shinpoong Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,608 |
Shionogi & Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,609 |
Shire Acquisitions Investments Ireland DAC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,610 |
Shukra Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,611 |
Sichuan Biokin Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,612 |
Sichuan Goldstone As Phrmctcl Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,613 |
Sichuan Huiyu Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,614 |
Sichuan Kelun Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,615 |
Sichuan Zitonggong Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,616 |
Siegfried Holding AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,617 |
SIGA Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,618 |
Sihuan Pharmaceutical Holdings Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,619 |
Silence Therapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,620 |
Simcere Pharmaceutical Group Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,621 |
Simply Better Brands Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,622 |
Simply Solventless Concentrates Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,623 |
Sinclair Pharma Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,624 |
Sinil Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,625 |
Sino Biopharmaceutical Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,626 |
SinoMab Bioscience Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,627 |
Sinotherapeutics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,628 |
Sinovac Biotech Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,629 |
Sinphar Pharmaceutical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,630 |
Sinsin Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,631 |
Sirnaomics Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,632 |
SK Biopharmaceuticals Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,633 |
SK Bioscience Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,634 |
SL Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,635 |
Slang Worldwide Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,636 |
Small Pharma Inc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,637 |
Smruthi Organics Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,638 |
SMS Lifesciences India Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,639 |
SMS Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,640 |
SNDL Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,641 |
Societal CDMO Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,642 |
SoftOx Solutions AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,643 |
Soho Global Health Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,644 |
Solara Active Pharma Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,645 |
Solasia Pharma KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,646 |
Solid Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,647 |
Soligenix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,648 |
Sorrento Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,649 |
Sotac Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,650 |
Source Naturl Fds and Hrbl Supplmnts Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,651 |
Specialty Natural Products PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,652 |
Spectral Medical Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,653 |
Square Pharmaceuticals PLC (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,654 |
SSY Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,655 |
ST Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,656 |
STADA Arzneimittel AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,657 |
Staidson Beijing BioPharmaceutcls Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,658 |
Standard Chem & Pharm Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,659 |
StateHouse Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,660 |
Ste Promotion Pharmaceutique du Mghrb SA (Morocco) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,661 |
Stella Pharma Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,662 |
StemRIM Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,663 |
Stock Trend Capital Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,664 |
Strides Pharma Science Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,665 |
Sudarshan Pharma Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,666 |
Sugentech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,667 |
Sumitomo Pharma Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,668 |
Summit Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,669 |
Sun Bio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,670 |
Sun Pharmaceutical Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,671 |
Sunflower Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,672 |
Sunil Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,673 |
Sunny Pharmtech Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,674 |
Sunshine Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,675 |
Sunshine Guojian Pharmcutcl Shngh Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,676 |
Supernus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,677 |
Supriya Lifescience Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,678 |
Surrozen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,679 |
Sutro Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,680 |
Suzhou Fushilai Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,681 |
Suzhou Zelgen Biopharmaceuticals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,682 |
Swedencare AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,683 |
Swedish Orphan Biovitrum AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,684 |
Sweet Earth Holdings Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,685 |
SYBLEU Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,686 |
Symbio Pharmaceuticals Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,687 |
SYN-Tech Chem & Pharm Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,688 |
SynAct Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,689 |
Syncom Formulations (India) Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,690 |
SynCore Biotechnology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,691 |
Syngen Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,692 |
Synmosa Biopharma Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,693 |
Synthaverse SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,694 |
T Man Pharmaceutical PCL (Thailand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,695 |
Taidoc Technology Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,696 |
TAIKO PHARMACEUTICAL CO LTD (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,697 |
TAISHO PHARMACEUTICAL HOLDINGS Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,698 |
Taisho Pharmaceutical Indonesia Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,699 |
Taiwan Advance Bio-Pharmaceutical Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,700 |
Takeda Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,701 |
Talphera Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,702 |
Target Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,703 |
Taro Pharmaceutical Industries Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,704 |
Tarsus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,705 |
Tascom Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,706 |
Tasly Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,707 |
TAUNS Laboratories Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,708 |
Tchaikapharma High Quality Medicines AD (Bulgaria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,709 |
TCI Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,710 |
TDSPharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,711 |
Techno Drugs Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,712 |
Tego Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,713 |
Tellgen Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,714 |
Telomir Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,715 |
Tempo Scan Pacific Tbk PT (Indonesia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,716 |
Terrascend Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,717 |
Teva Pharmaceutical Industries Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,718 |
Teva Pharmaceuticals USA, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,719 |
Tevogen Bio Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,720 |
Teyi Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,721 |
TG Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,722 |
The United Laboratories Intl. Hldgs Ltd. (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,723 |
Themis Medicare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,724 |
Theragen Etex Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,725 |
TherapeuticsMD Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,726 |
Theratechnologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,727 |
Theravance Biopharma Inc (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,728 |
Theriva Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,729 |
Third Harmonic Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,730 |
Tiaan Consumer Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,731 |
Tianda Pharmaceuticals Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,732 |
Tianjin Chase Sun Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,733 |
Tianjin Lisheng Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,734 |
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,735 |
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,736 |
Tianjin Ringpu Bio-Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,737 |
Tiansheng Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,738 |
Tibet Aim Pharm Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,739 |
Tibet Cheezheng Tibetan Medicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,740 |
Tibet Duo Rui Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,741 |
Tibet Rhodiola Pharmaceutical Holding Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,742 |
Tibet Weixinkang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,743 |
Tien Liang Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,744 |
Tikun Olam Cannbit Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,745 |
Tilray Brands Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,746 |
TILT Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,747 |
Tipharco Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,748 |
Titan Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,749 |
Titan Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,750 |
Tnth of Rmd fr Phtl Ind nd Dgt Rgt (Rmd) (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,751 |
Together Pharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,752 |
Tong Ren Tang Technologies Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,753 |
Tonghua Dongbao Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,754 |
Tonghua Golden-Horse Pharmcl Indu Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,755 |
Top Gum Industries Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,756 |
Torii Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,757 |
Torrent Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,758 |
TOT Biopharm International Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,759 |
Towa Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,760 |
Transcenta Holding Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,761 |
Transgene SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,762 |
Traphaco High Tech JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,763 |
Traphaco JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,764 |
Travere Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,765 |
Trident Lifeline Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,766 |
Trinity Biotech plc (ADR) (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,767 |
Triochem Products Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,768 |
TrivarX Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,769 |
Trulieve Cannabis Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,770 |
Tscan Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,771 |
TSH Biopharm Corp Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,772 |
Tsumura & Co (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,773 |
TTY Biopharm Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,774 |
Tuoxin Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,775 |
Turk Ilac Ve Serum Sanayi AS (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,776 |
Turnstone Biologics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,777 |
Tus Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,778 |
Twinlab Consolidated Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,779 |
Twist Bioscience Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,780 |
U-Neuron Biomedical Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,781 |
UBI Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,782 |
UCB SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,783 |
Ultragenyx Pharmaceutical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,784 |
UMeWorld Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,785 |
Uni-Bio Science Group Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,786 |
Uniao Quimica Farmaceutica Nacional S.A. (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,787 |
Unichem Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,788 |
Union Korea Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,789 |
Union Phrmcst Cmpny fr Mdcl Srvcs nd nvs (Egypt) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,790 |
Unite de Fabrication de Medicaments SA (Tunisia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,791 |
United Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,792 |
Universe Pharmaceuticals Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,793 |
Unjha Formulations Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,794 |
Upstream Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,795 |
USANA Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/29/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,796 |
UXN Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,797 |
Vaishali Pharma Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,798 |
Valeo Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,799 |
Valerio Therapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,800 |
Valiant Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,801 |
Valneva SE (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,802 |
Vanda Pharmaceuticals Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,803 |
Vasundhara Rasayans Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,804 |
Vaxart Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,805 |
VaxCell Biotherapeutics Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,806 |
Vcanbio Cell & Gene Engineering Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,807 |
Vectorite Biomedical Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,808 |
Veerhealth Care Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,809 |
Venture Life Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,810 |
Ventyx Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,811 |
Venus Remedies Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,812 |
Vera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,813 |
Vericel Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,814 |
Verici DX PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,815 |
Verrica Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,816 |
Vertex Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,817 |
Vetnostrum Animal Health Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,818 |
Vetoquinol SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,819 |
Vext Science Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,820 |
Viatris Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,821 |
Vicapsys Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,822 |
Vicore Pharma Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,823 |
VIDAC PHARMA HOLDING PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,824 |
Vidipha Central Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,825 |
Viet Nam Medicinal Materials JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,826 |
Vikram Thermo (India) Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,827 |
Vimian Group AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,828 |
Vincerx Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,829 |
Viracta Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,830 |
Virax Biolabs Group Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,831 |
Virbac SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,832 |
Vireo Growth Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,833 |
Viridian Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,834 |
Vista Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,835 |
Vistin Pharma ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,836 |
Vita Life Sciences Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,837 |
Vitality Products Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,838 |
Vitro Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,839 |
Vitrolife AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,840 |
Vitura Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,841 |
Vivanza Biosciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,842 |
Vivesto AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,843 |
Vivimed Labs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,844 |
VivoSim Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,845 |
Vivozon Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,846 |
Voronoi Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,847 |
Voyageur Pharmaceuticals Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,848 |
Wai Yuen Tong Medicine Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,849 |
Wakamoto Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,850 |
Walvax Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,851 |
Wanbury Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,852 |
Wedge Industrial Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,853 |
Weed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,854 |
Wellful Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,855 |
Wepon Pharmaceutical Holding Grup Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,856 |
Werewolf Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,857 |
Whanin Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,858 |
Whitehawk Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,859 |
Windlas Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,860 |
Windtree Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,861 |
Winston Medical Supply Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,862 |
Withus Pharmaceutical Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,863 |
Wockhardt Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,864 |
WooGene B&G CO., LTD (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,865 |
Woojung BIO Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,866 |
Wuhan Easy Diagnosis Biomedicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,867 |
Wuhan Hiteck Biological Pharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,868 |
Wuhan Hvsen Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,869 |
Wuhan Keqian Biology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,870 |
Wuhan YZY Biopharma Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,871 |
WuXi Biologics (Cayman) Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,872 |
WuXi XDC Cayman Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,873 |
Wyeth, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,874 |
X4 Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,875 |
Xcell Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,876 |
Xebra Brands Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,877 |
Xeris Biopharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,878 |
Xiamen Amoytop Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,879 |
Xiangxue Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,880 |
Xlife Sciences AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,881 |
XOMA Royalty Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,882 |
XORTX Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,883 |
XP Chemistries AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,884 |
Xtant Medical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,885 |
Y-mAbs Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,886 |
Yabao Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,887 |
Yantai Dongcheng Biochemicals Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,888 |
Yichang Hec Changjiang Pharmactcl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,889 |
Yifan Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,890 |
Yili Chuanning Biotechnology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,891 |
Youcare Pharmaceutical Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,892 |
YSP Southeast Asia Holding Bhd (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,893 |
Yuhan Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,894 |
Yung Zip Chemical Ind Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,895 |
Yungjin Pharm Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,896 |
YungShin Global Holding Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,897 |
Yunnan Baiyao Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,898 |
Yunnan Biovalley Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,899 |
Yuyu Pharma Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,900 |
Zai Lab Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,901 |
Zelluna ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,902 |
Zenith Drugs Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,903 |
Zenith Healthcare Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,904 |
Zenotech Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,905 |
Zentiva SA (Romania) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,906 |
Zeria Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,907 |
Zhaoke Ophthalmology Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,908 |
Zhejiang Anglikang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,909 |
Zhejiang Ausun Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,910 |
Zhejiang Benli Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,911 |
Zhejiang Chemsyn Pharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,912 |
Zhejiang Cheng Yi Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,913 |
Zhejiang CONBA Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,914 |
Zhejiang East Asia Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,915 |
Zhejiang Garden Biopharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,916 |
Zhejiang Haisen Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,917 |
Zhejiang Hisoar Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,918 |
Zhejiang Hisun Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,919 |
Zhejiang Huahai Pharmaceutical Co., Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,920 |
Zhejiang Jingxin Pharmaceutical Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,921 |
Zhejiang Jiuzhou Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,922 |
Zhejiang Jolly Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,923 |
Zhejiang Medicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,924 |
Zhejiang Nhu Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,925 |
Zhejiang Orient Gene Biotech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,926 |
Zhejiang Shapuaisi Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,927 |
Zhejiang Shengda Bio-pharm Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,928 |
Zhejiang Shouxiangu Pharmaceuticl Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,929 |
Zhejiang Starry Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,930 |
Zhejiang Sunflower Great Health Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,931 |
Zhejiang Tianyu Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,932 |
Zhejiang Wecome Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,933 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,934 |
Zhejiang Xianju Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,935 |
Zhejiang Xinguang Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,936 |
Zhejiang Yatai Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,937 |
Zhejiang Yongtai Technology Co., LTD. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,938 |
Zhengye Biotechnology Holding Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,939 |
Zhong Yuan Bio-Technology Holdings Ltd (Hong Kong) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,940 |
Zhongzhi Pharmaceutical Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,941 |
Zhuhai Rundu Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,942 |
Ziccum AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,943 |
Zim Laboratories Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,944 |
Zivo Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,945 |
Zoetis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2025 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,946 |
Zomedica Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,947 |
Zota Health Care Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,948 |
Zydus Lifesciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 1,949 |
Zyversa Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
